Recursion, Roche, and its Genentech subsidiary have unveiled a whole-genome map of specialized microglial immune cells that they plan to use toward revealing significant new targets in ...

Zero Knowledge Proof (ZKP) is built for pressure. Explore the tech and prepare for the whitelist, opening soon for early access.

Microsoft Azure has been experiencing a global outage since around 1600 UTC, or 0900 PDT on Wednesday, October 29, 2025. As Azure staggers back to its feet following an hours-long outage last night, ...

With the rise in adoption of agentic AI by companies for automation and increasing complexities of the newer versions, ...

Learn when to use 2-legged vs 3-legged OAuth flows for your authentication needs. Discover security vulnerabilities, implementation patterns, and how Workload Identity Federation eliminates credential ...

Epigram's River Korkmaz and Lily Scogings attended the opening night of the 30th Encounters Film Festival and were treated to a screening of Eternal Sunshine of the Spotless Mind (2004) followed by a ...

Perched where the Platte River meets the mighty Missouri, this riverside charmer isn’t just a dot on the map—it’s a master class in small-town allure that feels like stepping into a vintage postcard ...

Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its third quarter 2025 ...

Recursion Pharmaceuticals (RXRX) closed at $5.91 in the latest trading session, marking a -6.19% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 0.23% for the ...

Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...